Myomo - 2 Year Stock Price History | MYO
Historical daily share price chart and data for Myomo since 2017 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Myomo as of March 22, 2019 is 1.27.
| Myomo Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 1.4393 | 1.5500 | 1.7500 | 1.1700 | 1.2700 | -11.81% |
| 2018 | 2.8421 | 3.6500 | 5.4000 | 1.4400 | 1.4400 | -61.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.022B | $0.002B |
| Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $136.952B | 27.07 |
| Medtronic (MDT) | Ireland | $121.227B | 17.72 |
| Stryker (SYK) | United States | $72.547B | 26.60 |
| Boston Scientific (BSX) | United States | $51.696B | 25.20 |
| Baxter (BAX) | United States | $39.588B | 25.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.898B | 16.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $14.852B | 0.00 |
| ResMed (RMD) | United States | $14.350B | 27.21 |
| Bio-Rad Laboratories (BIO) | United States | $9.156B | 52.24 |
| Aurora Cannabis (ACB) | Canada | $9.141B | 64.50 |
| Hill-Rom Holdings (HRC) | United States | $6.962B | 21.53 |
| Perrigo (PRGO) | Ireland | $6.420B | 10.41 |
| Insulet (PODD) | United States | $5.800B | 1956.80 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.092B | 0.00 |
| ICU Medical (ICUI) | United States | $4.698B | 29.24 |
| Haemonetics (HAE) | United States | $4.311B | 38.24 |
| Hutchison China MediTech (HCM) | China | $3.810B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.637B | 0.00 |
| Neogen (NEOG) | United States | $3.108B | 47.74 |
| NuVasive (NUVA) | United States | $2.892B | 25.23 |
| Quidel (QDEL) | United States | $2.514B | 22.68 |
| Aphria (APHA) | $2.385B | 105.89 | |
| National Vision Holdings (EYE) | United States | $2.274B | 44.72 |
| Cardiovascular Systems (CSII) | United States | $1.346B | 966.50 |
| HEXO (HEXO) | $1.340B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.283B | 18.45 |
| VAREX IMAGING (VREX) | United States | $1.275B | 24.96 |
| AtriCure (ATRC) | United States | $1.081B | 0.00 |
| MacroGenics (MGNX) | United States | $0.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.911B | 24.60 |
| Cerus (CERS) | United States | $0.844B | 0.00 |
| PetIQ (PETQ) | United States | $0.831B | 23.77 |
| Omeros (OMER) | United States | $0.828B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.729B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.715B | 21.30 |
| OraSure Technologies (OSUR) | United States | $0.664B | 29.11 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.657B | 22.35 |
| Evolus (EOLS) | United States | $0.655B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.601B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.596B | 28.35 |
| Surmodics (SRDX) | United States | $0.563B | 81.90 |
| Quanterix (QTRX) | United States | $0.518B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.364B | 150.23 |
| Vapotherm (VAPO) | United States | $0.335B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.331B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.328B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.300B | 19.49 |
| Owens & Minor (OMI) | United States | $0.271B | 3.76 |
| Bovie Medical (APYX) | United States | $0.260B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.241B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.238B | 0.00 |
| Zynex (ZYXI) | United States | $0.145B | 15.52 |
| Fonar (FONR) | United States | $0.137B | 7.33 |
| Surface Oncology (SURF) | United States | $0.116B | 0.00 |
| Chimerix (CMRX) | United States | $0.102B | 0.00 |
| Female Health (VERU) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.096B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.091B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 19.84 |
| CAS Medical Systems (CASM) | United States | $0.072B | 0.00 |
| Neurotrope (NTRP) | United States | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.058B | 17.14 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.035B | 0.00 |
| Senestech (SNES) | United States | $0.029B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.018B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.016B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 15.29 |
